Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Archives of Industrial Hygiene and Toxicology
Volume 71 (2020): Issue 2 (June 2020)
Open Access
Renal changes and apoptosis caused by subacute exposure to Aroclor 1254 in selenium-deficient and selenium-supplemented rats
Naciye Dilara Zeybek
Naciye Dilara Zeybek
,
Ünzile Sur
Ünzile Sur
,
Ofcan Oflaz
Ofcan Oflaz
,
Pınar Erkekoğlu
Pınar Erkekoğlu
,
Aylin Balcı
Aylin Balcı
,
Gizem Özkemahlı
Gizem Özkemahlı
,
Ali Aşçı
Ali Aşçı
,
Murat Kızılgün
Murat Kızılgün
,
Oğuz Han Edebal
Oğuz Han Edebal
and
Belma Koçer-Gümüşel
Belma Koçer-Gümüşel
| Jun 29, 2020
Archives of Industrial Hygiene and Toxicology
Volume 71 (2020): Issue 2 (June 2020)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original article
Published Online:
Jun 29, 2020
Page range:
110 - 120
Received:
Nov 01, 2019
Accepted:
Jun 01, 2020
DOI:
https://doi.org/10.2478/aiht-2020-71-3360
Keywords
antioxidant enzymes
,
electron microscopy
,
histopathology
,
kidney
,
oxidative stress
,
polychlorinated biphenyls
,
Sprague-Dawley rats
,
TUNEL assay
,
ultrastructural changes
© 2020 Naciye Dilara Zeybek et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1
Kidney absolute and relative kidney weights in the experimental groups. Bars represent means ±SEM. Bars with different letters differ significantly from each other (p<0.05). A – absolute kidney weight B– relative kidney weight
Figure 2
Histopathological analysis of the renal cortex in the experimental groups. Narrowing in the Bowman’s space, renal corpuscular atrophy (white arrow), peritubular vascular congestion, oedema, desquamation of epithelial cells (black arrow) in the A group and necrotic tubules (dashed area) in the ASeD group. A– control; B– Se-supplemented (SeS) group; C– Se-deficient (SeD) group; D – A1254-treated (A) group; E– Se-supplemented A1254-treated (ASeS) group; F– Se-deficient A1254-treated (ASeD) group
Figure 3
Histopathological analysis of the renal medulla in the experimental groups. Denudation of renal tubular cells (black arrow) in the A group. A– control; B– Se-supplemented (SeS) group; C– Se-deficient (SeD) group; D– A1254-treated (A) group; E – Se-supplemented A1254-treated (ASeS) group; F– Se-deficient A1254-treated (ASeD) group
Figure 4
Ultrastructure of glomeruli in the experimental groups. Apoptotic (white arrow), endothelial (e), and mesangial (m) cells in the SeD group. Lipid droplets (arrow head) and lysosomes (black arrow) in the cytoplasm of podocytes and apoptotic cells (white arrow) in the A and ASeD groups. Regular pedicels (white arrow), effacement of the pedicels (black arrow) in the ASeS group. p – podocyte; m – mesangial cell; e – endothelial cell; A – control; B – Se-supplemented (SeS) group; C – Se-deficient (SeD) group; D – A1254-treated (A) group; E – Se-supplemented A1254-treated (ASeS) group; F – Se-deficient A1254-treated (ASeD) group
Figure 5
Ultrastructure of tubules in experimental groups. Lysosomes (white arrow) and karyolitic nuclei (black arrow) in the SeD group. Lysosomes (white arrow), apoptotic cells (black arrow head), and loss of microvilli in the A1254 group. Degeneration of tubular epithelial cells in the ASeD group. PT – proximal tubule; DT – distal tubule; m – mitochondria; mv – microvilli; A– control; B – Se-supplemented (SeS) group; C – Se-deficient (SeD) group; D – A1254-treated (A) group; E – Se-supplemented A1254-treated (ASeS) group; F – Se-deficient A1254-treated (ASeD) group
Figure 6
TUNEL assay of the renal cortex and apoptotic cell counts in the experimental groups. Positive nuclei for apoptosis are labeled pink. Arrows indicate TUNEL-positive (apoptotic) cells (400x magnification). Bars represent means ±SEM. Bars with different letters differ significantly from each other (p<0.05). A– control; B – Se-supplemented (SeS) group; C – Se-deficient (SeD) group; D – A1254-treated (A) group; E– Se-supplemented A1254-treated (ASeS) group; F – Se-deficient A1254-treated (ASeD) group
Figure 7
TUNEL assay of the renal medulla in experimental groups. Positive nuclei for apoptosis are labeled pink by the chromogenic reaction of Fast Red substrate by alkaline phosphatase (400x magnification).Arrows indicate TUNEL-positive (apoptotic) cells. Bars represent means ±SEM. Bars with different letters differ significantly from each other (p<0.05). A– control; B – Se-supplemented (SeS) group; C – Se-deficient (SeD) group; D – A1254-treated (A) group; E – Se-supplemented A1254-treated (ASeS) group; F – Se-deficient A1254-treated (ASeD) group
Figure 8
Antioxidant enzyme activities in the experimental groups. Bars represent means ±SEM. Bars with different letters differ significantly from each other (p<0.05). A – SOD activities; B – CAT activities; C – GPx1 activities SOD – superoxide dismutase; CAT – catalase; GPx1 – glutathione peroxidase; Se-supplemented (SeS) group; Se-deficient (SeD) group; A1254-treated (A) group; Se-supplemented A1254-treated (ASeS) group; Se-deficient A1254-treated (ASeD) group
Figure 9
TAOC (A), MDA (B), carbonyl group (C) and total GSH (D) levels in the study groups. Bars represent means ±SEM. Bars with different letters differ significantly from each other (p<0.05). MDA – malondialdehyde; TAOC – total antioxidant capacity; Se-supplemented (SeS) group; Se-deficient (SeD) group; A1254-treated (A) group; Se-supplemented A1254-treated (ASeS) group; Se-deficient A1254-treated (ASeD) group
Preview